Coronavirus Flash Update: July 6, 2020

Alston & Bird’s Coronavirus Flash provides updates on policy and regulatory actions under consideration across many important industries being monitored by our teams. Links to key government and legal resources are provided throughout the report.

Click here to view coronavirus-related News & Insights. Subscribe for updates.  

The Latest News

• U.S. COVID-19 cases exceed 2,879,697 and 127,422 U.S. deaths. (Source: CDC) (Updated 7/6/20)
  • The Texas Tribune reports that 8,181 people were hospitalized for COVID-19 in Texas. (7/5/20) (New)
  • Fifteen states broke records yesterday on their single day increase in COVID-19 cases according to Johns Hopkins University of Medicine: Alabama, Arizona, Arkansas, California, Florida, Georgia, Idaho, Montana, North Carolina, Oklahoma, Oregon, South Carolina, Tennessee, Texas, and West Virginia. (7/5/20) (New)
• U.S. stock market: On Thursday the markets were up for the day, with the Dow rising 92 points, the S&P 500 gaining 14 points, and the Nasdaq adding 53 points. The markets were closed Friday in observance of Independence Day. (New)
• HHS announced last week an agreement to obtain large supplies of the drug Remdesivir for use in the United States through Gilead Sciences to aid hospitals and state health departments to purchase the drug as allocated by HHS. This agreement secures 500,000 treatment courses of Remdesivir for hospitals, and their payments will be limited to no more than $3,200 per average treatment course at $390 per vial. (6/29/20) (New)
  • To qualify for purchases hospitals must submit data on their COVID-19 patients through the TeleTracking web portal by Monday at 8:00pm every two weeks starting on Monday, July 6 (today). (New)
• On Saturday, July 4, the President signed into law 4116 which reauthorizes the Paycheck Protection Program (PPP) through August 8. This extends the PPP loan assistance for small businesses which had been set to expire on June 30 for another 6 weeks. The bill passed both chambers last week with bipartisan support. (New)
• Several business groups urge the President and the National Governor’s Association to issue stronger guidance on face masks. The letter was signed by the U.S. Chamber of Commerce, the National Retail Federation, the National Association of Manufacturers, the American Council of Life Insurers, the Business Roundtable, and several others. (7/2/20) (New)

COVID-19 Federal & State Legislation   

• Bill 4.0: The House voted early last week to approve, by a vote of 234-179, an amended version of the Patient Protection and Affordability Enhancement Act, H.R. 1425, which seeks to bolster certain health coverage and affordability provisions of the Affordable Care Act (ACA). The Energy and Commerce Committee has posted a one page summary, section-by-section, and the text. The Senate GOP leadership does not plan to move forward on the House passed measure.
• Last Wednesday, the House passed the Invest Act, H.R. 2, a $1.5 trillion infrastructure investment package. While the vote was largely along party lines at 233-188, the Senate is expected to move forward on some version of the Invest Act when they return later this month.
• The HEROES Act was the first formal offer on a new emergency stimulus bill, 4.0: For the full details on the HEROES Act, H.R. 6800, which passed the House on May 15:
  • The HEROES Act text is available here.
  • A 1-pager and 71 page section-by-section summary are available here.
  • And an outline of the state and local funding provisions is here.
• The Paycheck Protection Flexibility Act, H.R. 7010, was enacted on June 5. To learn more, see this A&B Summary of the Paycheck Protection Flexibility Act. (6/5/20)
• Bill 3.5: Paycheck Protection Program and Health Care Enhancement Act, (R. 266) was enacted on April 24. Also available are a section-by-section summary and an overview of the health care provisions.
• A&B detailed summaries are below:
  • A&B Summary – 5 Small Business Provisions
  • A&B Summary – 5 Health Care Enhancement Provisions
• Bill 3.0: Coronavirus Aid, Relief, and Economic Security (CARES) Act, (R. 748) passed on March 27. A congressional section by section summary is available here.
• Congress has passed three coronavirus emergency response bills and the first two are below:
• Bill 1.0: Coronavirus Preparedness and Response Supplemental (CPPRS) (R. 6074) passed on March 5
• Bill 2.0: Families First Coronavirus Response Act (FFCRA) (R. 6201) passed on March 18

Transition to “Reopening”   

• State/Other Actions
  • For the latest information on state reopening decisions, see A&B 50-State Reopening Tracker - updated in each A&B Coronavirus Flash. (Updated 7/2/20)
• Administration Actions
• The Government Accountability Office (GAO) released a report on returning the federal workforce to the workplace. (6/25/20)
  • The CDC updated or released guidance for reopening:
  • K-12 Schools and Higher Education Institutions (6/30/20) (New)
  • Administrators of Institutions of Higher Education (6/30/20) (New)
  • Bars and Restaurants (Updated 6/30/20)
  • Pet Stores, Pet Distributors, and Pet Breeding Facilities (6/30/20) (New)
  • Domestic Travel Messaging for Transportation departments (6/29/20) (New)
  • Mitigating exposure in food markets (6/28/20) (New)
  • Use of cloth face covering to slow the spread (6/28/20)
  • Travel in the US (6/28/20)
  • Direct Service Providers (6/28/20)
  • Strategies for Optimizing Face Masks and for Eye Protection (6/28/20)
  • Pharmacies (6/28/20)

Department of Health and Human Services   

• HHS has a tracking feature that allows public viewing of all COVID-19 HHS grants and cooperative agreement awards on its website. The grants were distributed through programs in the ACF, ACL, ASPR, CDC, DHHS/OS, HRSA, IHS, NIH, and SAMHSA. (Updated 7/1/20)
• The HHS Agency for Health Resources and Quality (AHRQ) released a blog on next steps for expanding telehealth and telementoring during COVID-19. (7/1/20) (New)
• The HHS Office of Civil Rights maintains a list of COVID-19 complaint resolutions. (Updated 7/2/20)
• The HHS Indian Health Service announced the expansion of the Community Health Aide Program which provides education and training for tribal community health providers in the delivery of public health services. (7/2/20) (New)
• The HHS Office of Biomedical Advanced Research and Development Authority (BARDA) has announced they are expanding their partnership with Sonica Health to develop an early warning COVID-19 patch. (7/1/20) (New)
• HHS announced it is extending its partnership with national pharmacy and grocery retail chains CVS, Rite-Aid, Walgreens, Quest (through services at Walmart) and eTrueNorth (through services at Kroger, Health Mart, and Walmart) to provide COVID-19 testing. (6/30/20) (New)
• HHS, as authorized by the CARES Act, has re-established the Ready Reserve Corps to provide trained and ready personnel to fill critical public health needs. (6/30/20) (New)
• The HHS Substance Abuse and Mental Health Services Administration, jointly with CMS, released a mental health and substance use disorders resource guide on insurance coverage during the COVID-19 pandemic. (6/29/20) (New)
• The National Institutes of Health (NIH) posted a discussion on Rapid Acceleration of Diagnostics (RADx) between NIH Director Dr. Francis Collins and Dr. Bruce Tromberg, Director of the National Institute of Bioimaging and Bioengineering. (6/25/20)

HHS/CDC/CMS/HRSA CARES Act Provider Relief Funds   

• HHS - the CARES Act Provider Relief Fund (PRF) webpage and portal (Updated 7/1/20)
• And the PRF FAQs (Updated 6/30/20) have been updated and capture numerous modifications.
• HHS announced three new Provider Relief Fund allotments completing the initial $100 billion authorized by the CARES Act: the three allotments are safety net hospitals, second round funding for hot spot providers, and Medicaid and CHIP providers. (6/9/20)
• The CDC has posted an updated dataset of provider recipient specific payment from the Provider Relief Fund general distribution high impact targeted allocation and/or rural targeted allocation. The dataset includes who has attested to receiving one or more payments and agreed to the terms and conditions as of July 1. (Updated 7/2/20)
• HHS posted a resource on Provider Relief Fund disbursements to serve as summary of the key details. The CARES Act Provider Relief Fund hotline is (866) 569-3522. (6/18/20)
• A&B Hospital Provisions from all 4 bills tracker (Updated 7/5/20)
• A&B Provider Relief Fund Disbursement tracker (Updated 7/5/20)
• Centers for Disease Control and Prevention  

• The Centers for Disease Control and Prevention (CDC) COVIDView Weekly Summary is available. (Updated 7/3/20)
• The CDC weekly COVID forecast. (Updated 7/1/20)
• The CDC S. testing data. (Updated 7/5/20)
• The CDC updated its information on contact tracing resources and case investigation. (Updated 6/30/20)
• The CDC updated its information on epidemiology of COVID-19. (7/1/20) (New)
• The CDC updated information on antibody testing. 6/30/20) (New)
• The CDC is partnering with commercial laboratories to conduct a large-scale geographic seroprevalence survey. (6/26/20) (New)
• Updated procedures for completing PUI and CRF forms for persons under COVID-19 investigation. (Updated 6/28/20)
• The CDC has released new guidance for:
• People Who Need to Take Extra Precautions (Updated 7/2/20)
• Social media toolkit to help localize response efforts (7/2/20) (New)
• Infographic on Tracking MID-C and COVID-19 in US Children (7/1/20) (New)
• Testing in Homeless Shelters and Encampments (7/1/20) (New)
• Clinical Care for COVID-19 Patients (6/30/20) (New)
• Healthcare Professional Training (6/30/20) (New)
• Healthcare System Framework for COVID-19 care (6/30/20) (New)
• Clinical questions FAQs (Updated 6/29/20)
• Home Care Guidance for Public Health Departments (6/28/20) (New)
• Optimizing eye protection supplies (6/28/20) (New)
• Optimizing face mask supplies in healthcare settings (6/28/20) (New)
• Management of Visitors to Healthcare Facilities (6/28/20)
• Optimizing N95 use (6/28/20)
• Testing in Congregate Settings (6/27/20) (New)

Centers for Medicare & Medicaid Services  

• The Centers for Medicare and Medicaid Services (CMS) latest news alert. (Updated 6/30/20)
• For the latest COVID-19 related CMS guidance and FAQs visit the CMS Current Emergencies webpage. (Updated 7/1/20)
• CMS has posted FAQs on COVID-19 and Medicaid and CHIP to aid state Medicaid agencies. (6/30/20) (New)
• CMS released hospital visitation guidance for phase II. (6/26/20) (New)
• CMS updated its Toolkit on State Actions to Mitigate COVID-19 Prevalence in Nursing Homes. 6/26/20) (New)
• CMS released a Special Trends Report on health insurance exchange enrollment data during the COVID-19 pandemic. (6/25/20)

Food and Drug Administration   

• FDA provides a daily roundup on COVID-19 related actions. (Updated 7/2/20)
  • FDA updated its FAQs on Testing for SARS-CoV-2 relating to the development and performance of tests for SARS-CoV-2. (Updated 7/2/20)
  • FDA maintains its COVID-19 FAQs for the general public. (Updated 7/2/20)
  • FDA webpage for health professionals. (Updated 6/24/20)
  • The agency also maintains a public database of drug shortages. (Updated 7/2/20)
• The FDA updated the templates for laboratories and commercial manufacturers to facilitate serology testing. (7/2/20) (New)
• The FDA, jointly with the Federal Trade Commission, issued a warning letter to the Center for Wellness and Integrative Medicine for selling unapproved and unauthorized COVID-19 products. (7/1/20) (New)
• The FDA issued new emergency use authorizations (EUA) for:
• COVID-19 RT-PCR Peptide Nucleic Acid (PNA), a home self-collect nasal swab specimen kit by Kroger Co. (6/30/20) (New)
• Psoma COVID-19 RT Test by Psomagen, Inc., a qualitative detection test of nucleic acid from SARS-CoV-2 in upper respiratory swab specimens. (6/30/20) (New)
• LifeHope 2019-nCoV Real-Time RT-PCR Diagnostic Panel by LifeHope Labs. (6/29/20) (New)
• The FDA announced action to facilitate the development of safe and effective COVID-19 vaccines, and new guidance on the licensure of COVID-19 vaccines. (6/30/20) (New)
• The FDA released a podcast called "All About COVID-19 Testing". (6/30/20) (New)
• The FDA issued a warning letter to Curativa Bay Corporation for selling fraudulent COVID-19 products. (6/26/20) (New)

Small Business Administration   

• Small Business Administration (SBA) announced it had reopened the Economic Injury Disaster Loan and the Advance Program to small businesses and nonprofits. (6/15/20)
• The President signed into law 4116 which reauthorizes the Paycheck Protection Program (PPP) through August 8. This extends the PPP loan assistance for small businesses which had been set to expire on June 30 for another 6 weeks. (7/4/20) (New)
• The SBA Paycheck Protection Program (PPP):
• A PPP guidance on how to calculate maximum loan amounts has been posted. (6/26/20)
• The SBA has released an interim final rule on certain eligible payroll costs. (6/25/20)
• The PPP FAQs have been updated. (6/25/20)

Other Federal Agencies   

• The Environmental Protection Agency’s decision to end its temporary policy to exercise enforcement discretion for noncompliance of routine monitoring and reporting during the pandemic gets a full analysis in this A&B Advisory. (7/2/20) (New)
• The Federal Communications Commission (FCC) announced funding for rural health care providers for telecommunications and broadband services. (6/30/20) (New)
• The Federal Emergency Management Administration (FEMA) posted a fact sheet on coordinating public assistance during COVID-19. (7/1/20) (New)
• A&B reviews what COVID-19 means for health mergers. (7/1/20) (New)
• The Internal Revenue Service issued notice 2020-53 to provide tax relief for the low-income housing credit and bonds for qualified residential rental projects. (7/1/20) (New)
• The Department of Justice, HHS, and the Federal Trade Commission released an alert on contract tracing fraud schemes. (6/30/20) (New)
• For the latest in COVID-19 litigation read the latest issue of A&B's Class Action Roundup. (6/25/20)
• The Department of Labor announced a series of July webinars on COVID-19 related sick leave for employers: (6/29/20) (New)
• July 7, 1:00pm – 3:00pm EDT
• July 14, 1:00pm – 3:00pm EDT
• July 21, 1:00pm – 3:00pm EDT
• July 28, 1:00pm – 3:00pm EDT
• The Security and Exchange Commission (SEC) has changed its guidance on what COVID-19 issues corporations should disclose to investors. A&B offers a deeper dive on what to consider before you disclose. (6/30/20) (New)
• The Departments of Transportation, Homeland Security, and HHS issued new guidance on safe air travel for the airline industry. (7/2/20) (New)
• The Department of Transportation announced grants to 347 airports totaling $800 million as authorized by the CARES Act. (6/30/20) (New)

For background and the most up-to-date information, please visit the Centers for Disease Control and Prevention Coronavirus Disease 2019 website: HERE. The additional federal agency links are provided by the White House Coronavirus Task Force:   What You Should Know:

• How to Protect Yourself & Others
• What to Do If You Are Sick with COVID-19
• Symptoms
• Facts about COVID-19
• Guidance Documents

Information for Businesses:

• Information for Communities, Schools, and Businesses
• Workplaces during the COVID-19 Pandemic
• Cleaning and Disinfecting Your Facility
• Worker Safety and Support
• COVID-19 Critical Infrastructure Sector Response Planning
• General Business Frequently Asked Questions
• Information for Small Businesses
• SBA: COVID-19 Resources
• Treasury: Assistance for Small Businesses
• DOL: Guidance for Preparing Workplaces for Coronavirus
• DOL: COVID-19 and the American Workplace
• DOL: OHSA Resources for Workers and Employers on COVID-19
• WHO: Get Your Workplace Ready for COVID-19
• CISA: Risk Management for COVID-19
• CISA: Telework Guidance and Resources
• CISA: Guidance on the Essential Critical Infrastructure Workforce

Information for Travel and Transportation:

• Information for Travel
• Travel in the United States
• Public Health Considerations for Reopening Mass Transit During the Covid-19 Pandemic
• COVID-19 Travel Recommendations by Country
• Travel Restrictions to Prevent the Spread of Disease
• Airline Guidance
• Cargo Ship Guidance
• Maritime Resources
• Returning from International Travel
• Travelers Returning from Cruise Ship and River Cruise Voyages
• Travel: Frequently Asked Questions and Answers
• Travelers Prohibited from Entry to the United States
• Communication Resources for Travelers
• State: Travel Advisories
• State: Traveler’s Checklist
• State: Smart Traveler Enrollment Program
• DOT: FAQs from FTA Grantees Regarding COVID-19
• DOT: Expanded Emergency Declaration
• FAA: Guidance for Air Carriers and Crews

Alston & Bird Coronavirus Links

• Alston & Bird Coronavirus Response & Relief Web page
• To Subscribe to Alston & Bird Advisories
• For Alston & Bird COVID-19 Insights and Events
• Previous Alston & Bird Coronavirus Advisories (not included in the above)
• June 15
  • International Tax Advisory: Who Says You Can't Go Home? IRS Sends Care Package to Those Away From Home Due to COVID-19
• June 8
  • Into the Unknown: Employee Retention Credits Remain Murky
• June 5
  • Environmental, Land Use & Natural Resources Advisory: President Issues Executive Order on Expediting Infrastructure Investments
  • What's in Store: A&B Review of the Challenges for Retailers During COVID-19
• June 3
  • Grand Reopening: Guidelines for Resuming Business Operations in California Amid COVID-19
• June 1
  • Federal Tax Advisory: Disaster Losses
• May 29
  • Environment, Land Use & Natural Resources Advisory: Emergency Rule 9 Amendment Provides Deadlines for Statutes of Limitations
• May 22
  • A&B Environment and Land Use Briefing: COVID-19 Articles Included
• May 21
  • Prescribing Paid Sick Leave -- An Important Tool for Primary Care During the Pandemic: JAMA Health Forum
• May 18
  • International Tax Advisory: Proposed Treasury Regulations Clarify UBTI "Silo" Rule
  • Financial Services Litigation / Financial Services & Products Advisory: CFPB Reflects on the Impact of COVID-19 and Provides a Window into Future Enforcement
• May 15
  • A&B Investment Management Updates, including items reflecting the impact of the coronavirus pandemic.
• May 12
  • Finance Advisory: Ginnie Mae Extends PTAP/C19 Assistance to Multifamily MBS Program
  • A&B Guide to Telehealth Waivers and Regulatory Flexibilities
  • The Digital Download -- Alston & Bird's Privacy & Data Security Newsletter
• May 8
  • Finance Advisory: ESG During the Coronavirus Crisis -- Should You Care?
  • Health Care / Privacy & Data Security Advisory: Expansive Interoperability and Data-Sharing Requirements Require Attention Despite Delays in Enforcement
  • Financial Restructuring & Reorganization Advisory: Delaware Courts Leery of Shareholder Obstruction
• May 6
  • Finance Advisory: Federal Reserve Revises Main Street Lending Program, Adds Third Option
• May 5
  • Finance Advisory: Brexit and Its Potential Impact on Cross-Border Litigation Throughout Europe
  • Investment Management Advisory: Update on Relief Under the CARES Act for Fund Managers
• May 4
  • Food, Drug & Device/FDA Advisory: Examining the Drug Supply Chain -- How the Public Health Emergency Impacts DSCSA
• April 30
  • College & Universities Advisory: Schools Face Class Action as Parents and Students Sue for Refunds
  • White Collar Government & Internal Investigations Advisory: New PPP Funding Ups Ante for Compliance Failure--Audits on the Horizon
• April 29
  • Health Care / Health Care Litigation Advisory: COVID-19 A Tipping Point for Telehealth Expansion
• April 28
  • Labor & Employment Advisory: The New Executive Order Suspends Entry of Immigrant Visa Applicants into the U.S. for 60 days
• April 24
  • Commercial Litigation Advisory: COVID-19 Impacts on Statutes of Limitations
• April 23
  • International Trade & Regulatory Advisory: FEMA Issues Guidance on Exemptions for Critical PPE Export Restrictions
• April 22
  • Labor & Employment Advisory: Developing a Plan to Bring Your Employees Back to Work
• April 21
  • Financial Advisory: Forbearance Agreements in the age of COVID-19 and National Shelter-in-Place Orders
  • Antitrust / Mergers & Acquisitions / International Trade & Regulatory Advisory: COVID-19 Affect European Foreign Direct Investment Reviews: New EU Guidance Potentially Heralds Increased Protectionism
• April 20
  • Financial Advisory: FHFA Limits Servicer Advancing Obligations for Loans in COVID-19 Forbearance
• April 17
  • "INSIGHT: Businesses Better Brace for Post-Coronavirus Lawsuits" Bloomberg Law
  • Antitrust / Labor & Employment Advisory: Federal Antitrust Agencies Remind Businesses That Colluding on Labor Issues Remains Illegal During Pandemic
  • Labor & Employment / Health Care / Corporate & Finance Advisory: Ramping Up: What Does Restarting Look Like?
• April 16
  • International Tax Advisory: Risky Business - Allocating Losses When Your Supply Chain Is Disrupted
  • Finance Advisory: Ginnie Mae Expands Pass-Through Assistance Program to Finance Servicing Advances in Response to COVID-19
• April 15
  • "Force Majeure Clauses in the Face of COVID-19: Commercial Leasing Guidance (CA)," Lexis Practice Advisor
  • Federal Tax Advisory: IRS Issues COVID-19 Forbearance Guidance for REMICs and Investment Trusts
• April 14
  • Investment Advisory: Federal Reserve Announces Main Street Lending Program to Provide Liquidity to Small & Mid-Size Businesses
  • Investment Management Advisory: Relief Under the CARES Act for Fund Managers
• April 13
  • "As Pandemic Triggers Continuity Plans, What RIAs and BDs Should Ask Themselves," Financial Planning
  • FDA & Environment Advisory: Cleaning Up After COVID-19? What You Need to Know Before You Manufacture, Import, or Sell Sterilizers, Sanitizers, Purifiers, and Disinfectants
  • Securities Law Advisory: SEC Reminds Companies to Keep Their Disclosures Looking Forward
• April 10
  • Securities Law Advisory: ISS Offers COVID-19-Conscious Policy Guidance
• April 9
  • Federal Tax Advisory: IRS Provides Partnerships a Mechanism to Claim Benefit of Retroactive CARES Act Provisions
  • Financial Services Advisory: Agencies Update Their Interagency Statement on Reporting Loan Modifications
  • Early Securities Class Actions Highlight COVID-19 Litigation Risk (Law360)
  • FDA Compliance & Enforcement Advisory: FDA Issues New Guidance on Supply-Chain Disruption Notifications During COVID-19 Emergency
  • Financial Restructuring & Reorganization Advisory: Protecting Recoveries in a Pandemic: What Creditors Can Do Right Now
• April 7
  • Updated FAQs Regarding Paid Leave Obligations Under the Families First Coronavirus Response Act
  • Cyber Alert: Cybersecurity and COVID-19: Four Categories of Cyber Threats and Practical Tips in Response
• April 6
  • Antirust Advisory: Production and R&D Joint Ventures in a Pandemic: Reducing Antitrust Risk
  • Financial Services Advisory: Regulatory Agencies Issue Mortgage Servicing Guidance and FAQs for the CARES Act
  • White Collar, Government Investigations Advisory: CARES Act Follows Familiar Blueprint for Oversight and Enforcement
• April 3
  • EU State Aid Measures in the Fight Against COVID-19 Pandemic
• April 2
  • USPTO Announces Additional Limited Extensions Due to the COVID-19 Pandemic
  • Deadline for Reg BI and Form CRS Compliance Remains on Track
  • What Does the Coronavirus Mean for Companies and Their Critical Offshore Services?
• April 1
  • Federal Tax Advisory: Downward Stock Attribution for CFC Purposes
  • Hospital EMTALA Obligations Under Recent COVID-19 Waivers
  • CMS Issues Blanket Waivers from Physician Self-Referral Law Sanctions
• March 31
  • Additional Families First Coronavirus Response Act Paid Leave FAQs for Employers
  • SEC Extends Timeframe for Regulatory Relief for Investment Advisers and Investment Companies
  • Responsibility for Construction Site Safety in a Coronavirus World
• March 30
  • Keep Mystery to a Minimum in Your SEC COVID-19 Disclosures
  • How the CARES Act Will Affect Banking During the Coronavirus Emergency
  • Economy in Chaos: Is Bankruptcy Inevitable for My Business?
  • CMS Announces Expansion of Medicare's Accelerated and Advance Payment Program
• March 27
  • Utilization of Electronic Signatures and Records: What You Need to Know
  • SEC Extends Conditional Filing Relief to Companies Affected by COVID-19
  • COVID-19: What It May Mean for Landlords and Lenders Under Their CRE Facility Agreements
  • Congress Further Expands Medicare Telehealth Benefits with the CARES Act
• March 26
  • USTR to Consider Additional Tariff Exclusions Due to COVID-19 Pandemic
  • COVID-19 and Price Gouging
  • SEC Continues to Keenly Monitor Insider Trading During COVID-19 Pandemic
• March 25
  • Is the COVID-19 Outbreak an “Act of God”? Why It May Matter for Your Contracts
  • FDA and USDA Food Safety Response to COVID-19 & DHS “Critical Infrastructure” Classification of Food and Agriculture Sector
  • Does Your Force Majeure Provision Extend to the Coronavirus?
  • Competition Authorities Across Europe Relax Competition Law Enforcement During COVID-19 Outbreak
  • COVID-19 Impacts Antitrust Deal Reviews: New Procedures and Delays
• March 24
  • Health Care Providers with Exposure to COVID-19: What You Need to Know
  • Regulators Further Clarify Guidance Regarding Loan Modifications and Reporting
  • Avoiding Antitrust Risk as Industries Respond to the Coronavirus: Businesses Look to Collaborate & Federal Government Offers Expedited Avenues
• March 23
  • FDA Continues to Accelerate Availability of COVID-19 Tests
  • CFTC Issues No-Action Letter Offering Regulatory Relief for CPOs
  • Building a Case for Force Majeure in Construction Contracts
• March 20
  • Employee Benefits & Executive Compensation Advisory: Coronavirus Impact on Health Benefits: A Deeper Dive
  • FDA Compliance & Enforcement Advisory: FDA Temporarily Postpones Routine Domestic Inspections
• March 19
  • Antitrust / Mergers & Acquisitions Advisory: COVID-19 Impacts Antitrust Deal Reviews: New Procedures and Delays
  • Construction Advisory: Five Best Practices for Construction Industry Stakeholders During the Coronavirus Pandemic
  • Labor & Employment Advisory: Employee Leave Requirements Under the Families First Coronavirus Response Act
  • Labor & Employment / Health Care Advisory: Coronavirus (COVID-19) FAQs for Employers
• March 18
  • Cyber Alert: Six Practical Tips for Practicing Cyberhygiene in the Middle of a Global Pandemic
  • Advisory: Are You an "Essential Business" in California Counties Where Shelter-in-Place Order Have Been Issued?
• March 17
  • Finance Advisory: Coronavirus and Securitization: Disclosure and Diligence Issues
• March 16
  • Securities Law Advisory: SEC Provides Guidance on the Possible Impacts of COVID-19 on Annual Meetings
  • Health Care / Cybersecurity Preparedness & Response Advisory: COVID-19 and HIPAA: Privacy, Security, and Breach Response During a Global Pandemic
• March 13
  • Financial Services & Products Advisory: FINRA Guidance: COVID-19 and Business Continuity Planning
  • Food, Drug & Device/FDA Advisory: FDA Seeks Help to Solve Personal Protective Equipment Shortages
  • Securities Litigation Advisory: Securities Litigation Risk Arising Out of the Coronavirus Pandemic
• March 12
  • FDA Compliance & Enforcement Advisory: FDA Postpones Foreign Inspections Through April 2020: Considerations for Industry
• March 10
  • Labor & Employment / Health Care Advisory: Coronavirus, Employers, and Domestic Travel: A Complicated Business Decision
• March 6
  • Securities Law Advisory: SEC Provides Conditional Relief to Companies Affected by COVID-19
• March 5
  • Health Care Advisory: Congress Expands Medicare Telehealth Benefit Amid Coronavirus Concerns
• February 28
  • Labor & Employment / Health Care Advisory: The Coronavirus: Employer and Workplace Considerations